Seqirus UK
Chemicals & Related Products · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
United KingdomWebsite
www.flu.comRevenue
$66.3 MillionIndustry
About Seqirus UK
CSL Seqirus is one of the world's largest influenza vaccine providers. As a subsidiary of CSL, the company focuses on discovering, developing, and delivering vaccine solutions to safeguard public health globally. Its portfolio includes influenza vaccines, COVID-19 vaccines, antivenoms, and the Q fever vaccine. The company operates state-of-the-art manufacturing facilities across three continents, including sites in the United Kingdom, United States, and Australia, utilizing egg-based and cell-based vaccine technology. CSL Seqirus serves global public health partners and governments, providing seasonal, pre-pandemic, and pandemic response capabilities through a globally integrated supply chain.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSeqirus UK Org Chart
Compare Similar Companies to Seqirus UK
Compare insights from companies similar to Seqirus UK, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Seqirus UK Tech Stack
A closer look at the technologies used by Seqirus UK
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seqirus UK
Sign Up For FreeTo access detailed company insights
CSL Seqirus is one of the world's largest influenza vaccine providers. As a subsidiary of CSL, the company focuses on discovering, developing, and delivering vaccine solutions to safeguard public health globally. Its portfolio includes influenza vaccines, COVID-19 vaccines, antivenoms, and the Q fever vaccine. The company operates state-of-the-art... Read More